Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.
Nishijima
Koji
K
Shukunami
Ken-ichi
K
Kotsuji
Fumikazu
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002177:Candidiasis / Q000503:physiopathology*; D002981:Clindamycin / Q000009:adverse effects* / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000503:physiopathology; D018805:Sepsis / Q000503:physiopathology*; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D002981:Clindamycin